Clinical-stage biotech harnessing exosomes.
| Date | Round | Amount |
|---|---|---|
| Apr 2024 | Series A EXO Biologics, a Liege exosome biotech, raised up to EUR16M in Series A (EUR9M equity plus EUR7M subsidies). | $17.3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.